Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock Rated "Moderate Buy" by Wall Street Brokerages

Key Points

• Analyst sentiment is moderately positive: Seven of 14 brokerages rate Sabra Healthcare REIT a buy and seven recommend holding the stock, with an average 12-month price target of $22.23 versus its recent $19.77 price.
• Institutional ownership remains high at 99.40%, while CEO Richard Matros sold 200,000 shares for approximately $4.17 million under a pre-arranged Rule 10b5-1 trading plan.
• Sabra reported quarterly revenue of $230.11 million, up 24.7% year over year, but missed earnings expectations; it also pays a $0.30 quarterly dividend, equivalent to a 6.1% annualized yield.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fourteen brokerages that are presently covering the firm, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $22.23.

SBRA has been the subject of several recent analyst reports. Truist Financial upped their price objective on shares of Sabra Healthcare REIT from $22.00 to $24.00 and gave the stock a "buy" rating in a research report on Wednesday, July 22nd. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an "underperform" rating to a "market perform" rating in a research report on Thursday, August 6th. Weiss Ratings downgraded shares of Sabra Healthcare REIT from a "buy (b)" rating to a "hold (c+)" rating in a report on Tuesday, August 4th. Barclays increased their price target on shares of Sabra Healthcare REIT from $21.00 to $23.00 and gave the stock an "equal weight" rating in a research report on Monday, August 31st. Finally, Wall Street Zen upgraded shares of Sabra Healthcare REIT from a "sell" rating to a "hold" rating in a research report on Sunday, June 28th.

Insider Activity at Sabra Healthcare REIT

In related news, CEO Richard Matros sold 200,000 shares of the company's stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the completion of the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at $34,529,599.38. This represents a 10.77% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 1.09% of the company's stock.

Institutional Trading of Sabra Healthcare REIT

Several large investors have recently bought and sold shares of SBRA. Sumitomo Mitsui Trust Group Inc. grew its position in Sabra Healthcare REIT by 6.8% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,208,600 shares of the real estate investment trust's stock worth $61,701,000 after acquiring an additional 203,226 shares during the last quarter. Dimensional Fund Advisors LP raised its position in Sabra Healthcare REIT by 7.8% in the first quarter. Dimensional Fund Advisors LP now owns 3,725,337 shares of the real estate investment trust's stock valued at $71,640,000 after purchasing an additional 269,793 shares during the last quarter. Legal & General Group Plc raised its position in Sabra Healthcare REIT by 16.5% in the fourth quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust's stock valued at $27,031,000 after purchasing an additional 201,667 shares during the last quarter. Lasalle Investment Management Securities LLC acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at about $66,938,000. Finally, Readystate Asset Management LP acquired a new stake in shares of Sabra Healthcare REIT during the second quarter valued at about $1,400,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Trading Up 0.4%

Shares of NASDAQ:SBRA opened at $19.77 on Friday. The business's 50 day simple moving average is $20.73 and its 200 day simple moving average is $20.18. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $22.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07. The company has a market capitalization of $5.05 billion, a P/E ratio of 76.04, a P/E/G ratio of 1.50 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.27). The company had revenue of $230.11 million during the quarter, compared to analyst estimates of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. Sabra Healthcare REIT's revenue was up 24.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.38 earnings per share. On average, research analysts anticipate that Sabra Healthcare REIT will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were paid a $0.30 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.1%. Sabra Healthcare REIT's dividend payout ratio (DPR) is presently 461.54%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.